SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 607 filers reported holding SEAGEN INC in Q3 2023. The put-call ratio across all filers is 3.99 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,996,333 | +10.5% | 9,410 | +0.3% | 0.00% | +50.0% |
| Q2 2023 | $1,806,044 | +38.7% | 9,384 | +45.9% | 0.00% | 0.0% |
| Q1 2023 | $1,302,490 | +63.4% | 6,433 | +3.7% | 0.00% | +100.0% |
| Q4 2022 | $797,277 | +3.4% | 6,204 | +10.2% | 0.00% | 0.0% |
| Q3 2022 | $771,000 | -22.4% | 5,629 | +0.1% | 0.00% | -50.0% |
| Q2 2022 | $994,000 | +106.2% | 5,621 | +67.7% | 0.00% | +100.0% |
| Q1 2022 | $482,000 | -10.1% | 3,352 | -3.3% | 0.00% | 0.0% |
| Q4 2021 | $536,000 | +10.5% | 3,467 | +21.3% | 0.00% | 0.0% |
| Q3 2021 | $485,000 | +264.7% | 2,858 | +238.2% | 0.00% | – |
| Q2 2021 | $133,000 | -27.3% | 845 | -35.6% | 0.00% | – |
| Q1 2021 | $183,000 | -44.2% | 1,313 | -30.0% | 0.00% | -100.0% |
| Q4 2020 | $328,000 | – | 1,875 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |